Click on Protocol Number of interest to view study-related documentation or download data files. (DTMC data files are under development.)
Division Study Number Title Investigator(s) Release Date
CTN NIDA-CTN-0047 Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) Michael P. Bogenschutz, M.D., Dennis Donovan, Ph.D. Sep 02, 2014
CTN NIDA-CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB) Walter Ling, M.D. Apr 24, 2015
CTN NIDA-CTN-0049 Project HOPE - Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users Lisa Metsch, Ph.D., Carlos del Rio, M.D. Sep 07, 2018
CTN NIDA-CTN-0051 Extended-Release Naltrexone vs. Burpenorphine for Opioid Treatment John Rotrosen, M.D. Jan 12, 2018
CTN NIDA-CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC) Theresa Winhusen, Ph.D. May 14, 2014
CTN NIDA-CTN-0053 Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT) Kevin M. Gray, MD Jul 13, 2018
CTN NIDA-CTN-0056 Testing and Linkage to HIV Care in China: A Cluster Randomized Trial Zunyou Wu, MD, PhD Sep 14, 2017
CTN NIDA-CTN-0059 The TAPS Tool: Screen and Brief Assessment Tool Validation Study Robert P Schwartz, M.D., Li-Tzy Wu, Psy.D., Jennifer McNeely, M.D. Sep 14, 2017
DTMC NIDA-CTO-0001 Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence Eugene Somoza, M.D. Dec 04, 2014
DTMC NIDA-CTO-0002 Safety Evaluation Of Cocaine Treatment Medication, Modafinil: Interactions With Intravenous Cocaine Robert J. Malcolm, M.D., C. Lindsay DeVane, Pharm.D. Aug 01, 2016